Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
- Institution
- CEDARS-SINAI MEDICAL CENTER, CA
- Principal investigator
- Joshua John Breunig
- Funding
- $463K
- Duration
- 2024–2028
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY / ABSTRACT The cerebellum is an exquisitely laminated structure regulating balance, voluntary motor coordination and modulating language and cognition through connections with the forebrain. Sitting just under the forebrain, the cerebellum is estimated to contain roughly 80% of the neurons in the human brain. Accordingly, cerebellar dysgenesis, pathology, or dysfunction is associated with a host of diseases or disorders, including ataxia, autism, and intellectual deficit. Most cerebellar neurons are a subtype called cerebellar granule cells (CGCs), which are generated embryonically from a structure termed the rhombic lip (RL)—a germinal zone residing at the interface between the ventricular zone (VZ) and roof plate of the fourth ventricle. The mechanisms leading to the specification of the RL germinal niche and subsequent generation of granule cells remain incompletely understood. Specifically, the epigenetic and transcriptomic changes underlying how the ventricular zone precursor cells take on the lineage fate of the RL are largely unknown. We have generated a novel conditional knockout (cKO) mouse for TOX3, a member of the TOX family of transcription factors previously associated with the regulation of epigenetics in T cells. Loss of TOX3 prior to RL specification leads to almost complete agenesis of CGCs and 100% penetrant ataxia. We hypothesize that TOX3 mediates an epigenetic switch necessary for the generation of cerebellar granule cell precursors from the rhombic lip and associated ventricular zone—the loss of which results in developmental ataxia. Using a combination of state-of-the- art single cell approaches spanning key developmental time points in this murine model system, we will uncover the mechanisms by which TOX3 regulates cerebellar histogenesis. We propose to carry out this work in two parts. The focus of Specific Aim 1 is to interrogate the epigenetic and transcriptomic consequences of cKO of Tox3 using CUT&RUN for histone marks, and multimodal single- cell RNA- and ATAC-sequencing to determine genetic networks regulating VZ/RL precursors and CGC genesis. The main goal of Specific Aim 2 is to define the role of TOX3 on murine cerebellar lineages using inducible Cre drivers and somatic mutagenesis.
Research team
- Joshua John BreunigPI
- Jonathan G KayePI
LOADING MOONBASE SCORE
Questions for CEDARS-SINAI MEDICAL CENTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Cedars-Sinai Medical CenterNot yet scored
Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis
Joshua John Breunig · $410K · 2024–2027
- NIH · Cedars-Sinai Medical Center68
Nucleocapsid bioparticles eliciting multi-pronged attack on tumor metastases
Lali K Medina-Kauwe · $382K · 2022–2027
- NIH · Cedars-Sinai Medical Center51
Characterizing Older Mexican (American) Participation in Activity Digitally, Reliably, and Ecologically with the CART Platform (COMPADRE CART): Implications for Cognition and ADRD
Zachary Beattie · $716K · 2022–2027